We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.27%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$56.6B
AUM Growth
-$4.33B
(-7.1%)
Cap. Flow
-$5.51B
Cap. Flow
% of AUM
-9.73%
Top 10 Holdings %
Top 10 Hldgs %
36.93%
Holding
1,739
New
42
Increased
177
Reduced
1,384
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$201M |
| 2 |
Oracle
ORCL
|
+$135M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$123M |
| 4 |
Invesco MSCI USA ETF
PBUS
|
+$80.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$267M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 3 |
NVIDIA
NVDA
|
+$172M |
| 4 |
JPMorgan Chase
JPM
|
+$137M |
| 5 |
Apple
AAPL
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.12% |
| 2 | Financials | 12.63% |
| 3 | Healthcare | 12.38% |
| 4 | Communication Services | 10.27% |
| 5 | Consumer Discretionary | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Rexford Industrial Realty
REXR
$8.65B
| $567K | ﹤0.01% |
14,651
-29,700
| -67% | -$1.22M |
|
927
Bio-Techne
TECH
$11.2B
| $566K | ﹤0.01% |
9,627
-31,000
| -76% | -$1.88M |
|
928
Americold
COLD
$4.26B
| $566K | ﹤0.01% |
44,000
-130,034
| -75% | -$1.59M |
|
929
Watts Water Technologies
WTS
$11.3B
| $565K | ﹤0.01% |
2,047
-3,945
| -66% | -$1.09M |
|
930
Donaldson
DCI
$10.8B
| $564K | ﹤0.01% |
6,360
-8,800
| -58% | -$764K |
|
931
BioMarin Pharmaceuticals
BMRN
$11.9B
| $560K | ﹤0.01% |
9,418
-19,250
| -67% | -$1.05M |
|
932
Wyndham Hotels & Resorts
WH
$5.64B
| $559K | ﹤0.01% |
7,400
-3,250
| -31% | -$245K |
|
|
TEM
933
Tempus AI
TEM
$7.73B
| $558K | ﹤0.01% |
9,445
-9,615
| -50% | -$752K |
|
934
Liberty Live Group Series C
LLYVK
$9.59B
| $557K | ﹤0.01% |
6,692
-10,200
| -60% | -$876K |
|
935
TD Synnex
SNX
$20.6B
| $554K | ﹤0.01% |
3,689
-8,300
| -69% | -$1.27M |
|
936
AGCO
AGCO
$8.45B
| $551K | ﹤0.01% |
5,283
-6,963
| -57% | -$741K |
|
937
Globus Medical
GMED
$11.1B
| $551K | ﹤0.01% |
6,308
-18,445
| -75% | -$1.4M |
|
938
Wayfair
W
$12.3B
| $550K | ﹤0.01% |
5,475
-12,150
| -69% | -$1.17M |
|
939
GFL Environmental
GFL
$14.6B
| $546K | ﹤0.01% |
12,700
| – | – |
|
940
Huazhu Hotels Group
HTHT
$13.4B
| $546K | ﹤0.01% |
11,600
| – | – |
|
941
Box
BOX
$4.49B
| $544K | ﹤0.01% |
18,185
-93,738
| -84% | -$2.94M |
|
942
Procore
PCOR
$7.55B
| $543K | ﹤0.01% |
7,468
-15,350
| -67% | -$1.14M |
|
943
D-Wave Quantum Inc. Common Stock
QBTS
$6.37B
| $540K | ﹤0.01% |
20,650
-29,700
| -59% | -$865K |
|
944
Moderna
MRNA
$22.2B
| $537K | ﹤0.01% |
18,200
-105,975
| -85% | -$2.88M |
|
945
Alexandria Real Estate Equities
ARE
$9.47B
| $536K | ﹤0.01% |
10,962
-18,481
| -63% | -$1.09M |
|
946
Chemed
CHE
$7.12B
| $533K | ﹤0.01% |
1,245
-2,074
| -62% | -$903K |
|
947
Jackson Financial
JXN
$8.58B
| $530K | ﹤0.01% |
4,971
-11,230
| -69% | -$1.12M |
|
948
Blue Owl Capital
OWL
$6.6B
| $521K | ﹤0.01% |
34,904
-67,600
| -66% | -$1.06M |
|
949
Western Alliance Bancorporation
WAL
$8.91B
| $516K | ﹤0.01% |
6,140
-12,100
| -66% | -$983K |
|
950
Glaukos
GKOS
$9.71B
| $516K | ﹤0.01% |
4,566
-7,465
| -62% | -$713K |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Ensign Peak Advisors held 1,739 positions worth $56.6B, down 7.1% from $60.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Ensign Peak Advisors withdrew a net $5.51B in Q4 2025, closing 54 positions and reducing 1,384 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ensign Peak Advisors opened a new position in Invesco MSCI USA ETF worth $81.3M.
- Ensign Peak Advisors's largest Q4 2025 buy was Invesco MSCI USA ETF: 1,188,232 shares worth $81.3M.
- Ensign Peak Advisors added most to Eli Lilly in Q4 2025, an estimated $201M increase.
- Ensign Peak Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $267M.
- Ensign Peak Advisors fully exited iShares Core S&P 500 ETF in Q4 2025, selling an estimated $125M.
- Ensign Peak Advisors's ten largest holdings make up 37% of its $56.6B portfolio in Q4 2025.
- Ensign Peak Advisors opened 42 new positions and closed 54 in Q4 2025.
- Ensign Peak Advisors's portfolio value fell 7.1% quarter-over-quarter to $56.6B.
Based on Ensign Peak Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.